Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Factors in the Era of Targeted Therapies in CLL.

Current hematologic malignancy reports - 1 Apr 2018

Boddu Prajwal, Ferrajoli Alessandra

Abstract excerpt

PURPOSE OF REVIEW: Chronic lymphocytic leukemia is heterogeneous disease characterized by a variable clinical course that is greatly influenced by various patient and disease characteristics. Over the last two decades, advent of new diagnostic methodologies has led to the identification of several factors of prognostic and predictive relevance. Furthermore, recent advances in next-generation sequencing techniques...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to ATM gene
Share to NOTCH1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Mutation

Share to Neoplasm Proteins

Share to Prognosis

Source

Identifiers

PMID: 29473123
DOI: 10.1007/s11899-018-0439-9

Genes

ATM
NOTCH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Factors in the Era of Targeted Therapies in CLL.PMID 29473123Read ↗

Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.Semantic proximity Read ↗

Prognostic factors and risk stratification in chronic lymphocytic leukemia.Semantic proximity Read ↗

Novel prognostic molecular factors: a quantum leap in the field of chronic lymphocytic leukemia.Semantic proximity Read ↗

Chronic Lymphocytic Leukemia: Prognostic/Predictive Factors in the Era of Novel DrugsSemantic proximity Read ↗

Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Semantic proximity Read ↗

[Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia].Semantic proximity Read ↗

Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?Semantic proximity Read ↗

Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.Semantic proximity Read ↗

Genomic Features: Impact on Pathogenesis and Treatment of Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia?Semantic proximity Read ↗

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemiaSemantic proximity Read ↗

Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.